Combined effects of targeted blood pressure, oxygenation, and duration of device-based fever prevention after out-of-hospital cardiac arrest on 1-year survival: post hoc analysis of a randomized controlled trial
M Meyer(Jisc), Jesper Kjærgaard(Copenhagen University Hospital), Rasmus Paulin Beske(Jisc), Christian Hassager(Copenhagen University Hospital), Johannes Grand(Jisc), Vibeke Lind Jørgensen(Jisc), Matilde Winther‐Jensen(Jisc), Henrik Schmidt(Odense University Hospital), Benjamin Nyholm(Jisc), Ditte Bekker‐Jensen(Odense University Hospital), Laust Emil Roelsgaard Obling(Copenhagen University Hospital), Jacob Eifer Møller(Copenhagen University Hospital), Britt Borregaard(University of Southern Denmark), Anna Sina P. Meyer(Copenhagen University Hospital), Simon Mølstrøm(Odense University Hospital)
Cited by 11
Related Papers
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
|New England Journal of Medicine|2016|1.7k
Left Atrial Volume
|Circulation|2003|688
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
|European Journal of Heart Failure|2016|561
Noninvasive estimation of left ventricular filling pressure by e/e′ is a powerful predictor of survival after acute myocardial infarction
|Journal of the American College of Cardiology|2004|541